Diagnosis and Treatment of Primary Aldosteronism. A Single-Center Study
By: Ilonczai Hunor and Réti Zsuzsanna
References
- Leslie SW, Muppidi V, Gupta S. Hyperaldosteronism. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 [cited 2026 Mar 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK499983/ PubMed PMID: 29763159.
- Wu X, Yu J, Tian H. Cardiovascular risk in primary aldosteronism. Medicine (Baltimore). 2019 Jun 28;98(26):e15985. doi:10.1097/MD.0000000000015985 PubMed PMID: 31261504; PubMed Central PMCID: PMC6617487.
- Adler GK, Stowasser M, Correa RR, Khan N, Kline G, McGowan MJ, et al. Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Aug 7;110(9):2453–95. doi:10.1210/clinem/dgaf284
- Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016 May 1;101(5):1889–916. doi:10.1210/jc.2015-4061
- Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol. 2017 Apr 11;69(14):1811–20. doi:10.1016/j. jacc.2017.01.052 PubMed PMID: 28385310.
- Ito Y, Takeda R, Karashima S, Yamamoto Y, Yoneda T, Takeda Y. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. Hypertens Res. 2011 Jan;34(1):98–102. doi:10.1038/hr.2010.166
- Käyser SC, Dekkers T, Groenewoud HJ, Van Der Wilt GJ, Carel Bakx J, Van Der Wel MC, et al. Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. J Clin Endocrinol Metab. 2016 Jul;101(7):2826–35. doi:10.1210/ jc.2016-1472
- Salle SPL, Brown JM, Tsai CH, Hundemer GL, Vaidya A. Subclinical primary aldosteronism. Arch Endocrinol Metab. 70(spe1):e250400. doi:10.20945/2359-4292-2025-0400 PubMed PMID: 41312955; PubMed Central PMCID: PMC12668193.
- Ariens J, Horvath AR, Yang J, Choy KW. Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care. Endocrine. 2022 Jun;77(1):11–20. doi:10.1007/s12020-022-03084-x
- Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018 Jan;6(1):41–50. doi:10.1016/S2213-8587(17)30319-4
- Hundemer GL, Agharazii M, Madore F, Vaidya A, Brown JM, Leung AA, et al. Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study. Circulation. 2024 Jan 9;149(2):124–34. doi:10.1161/ CIRCULATIONAHA.123.066389 PubMed PMID: 38031887; PubMed Central PMCID: PMC10841691.
- Jaffe G, Gray Z, Krishnan G, Stedman M, Zheng Y, Han J, et al. Screening Rates for Primary Aldosteronism in Resistant Hypertension. Hypertension. 2020 Mar;75(3):650–9. doi:10.1161/HYPERTENSIONAHA.119.14359
- Hundemer GL, Imsirovic H, Vaidya A, Yozamp N, Goupil R, Madore F, et al. Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study. Hypertens Dallas Tex 1979. 2022 Jan;79(1):178–86. doi:10.1161/HYPERTENSIONAHA.121.18118 PubMed PMID: 34657442; PubMed Central PMCID: PMC8664996.
- Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021 Dec;9(12):876–92. doi:10.1016/S2213-8587(21)00210-2
- Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic Outcomes and Mortality in Medically Treated Primary Aldosteronism: A Retrospective Cohort Study. Lancet Diabetes Endocrinol. 2018 Jan;6(1):51–9. doi:10.1016/S2213-8587(17)30367-4 PubMed PMID: 29129576; PubMed Central PMCID: PMC5953512.
- Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, et al. Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism. Hypertension. 2007 Nov;50(5):911–8. doi:10.1161/HYPERTENSIONAHA.107.095448
- Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017 Sep;5(9):689–99. doi:10.1016/S2213-8587(17)30135-3
- Li F, Wan C. Risk factors for persistent hypertension in primary aldosteronism after surgery: a systematic review and meta-analysis. Front Physiol. 2025 Aug 7;16:1632450. doi:10.3389/fphys.2025.1632450
- Buffolo F, Cavaglià G, Burrello J, Amongero M, Tetti M, Pecori A, et al. Quality of life in primary aldosteronism: A prospective observational study. Eur J Clin Invest. 2021 Mar;51(3):e13419. doi:10.1111/eci.13419
DOI: https://doi.org/10.2478/orvtudert-2025-0011 | Journal eISSN: 2537-5059 | Journal ISSN: 1453-0953
Language: English
Page range: 134 - 148
Published on: Jul 2, 2026
Published by: Transylvanian Museum Society
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 Ilonczai Hunor, Réti Zsuzsanna, published by Transylvanian Museum Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.